High-dose fish oil and antioxidants in Crohn's disease and the response of bone turnover: a randomised controlled trial

Trebble, Timothy M., Stroud, Mike A., Wootton, Stephen A., Calder, Philip C., Fine, David R., Mullee, Mark A., Moniz, Caje and Arden, Nigel K. (2005) High-dose fish oil and antioxidants in Crohn's disease and the response of bone turnover: a randomised controlled trial British Journal of Nutrition, 94, (2), pp. 253-261. (doi:10.1079/BJN20051466).


Full text not available from this repository.


Crohn's disease is associated with altered bone turnover that may be influenced by nutritional status, the systemic inflammatory response, cytokine production by circulating (peripheral blood) mononuclear cells (PBMC) and antioxidant micronutrient intake. High-dose fish oil is associated with reductions in disease relapse and inflammatory markers, and modulates PBMC function. The effect of fish oil plus antioxidants on bone turnover and PBMC function (the production of interferon-gamma and prostaglandin E2) in Crohn's disease was investigated in a randomised-controlled trial. Patients with currently or recently raised biochemical markers of inflammation (C-reactive protein > or = 6.9 mg/l or erythrocyte sedimentation rate > or =18 mm/h) received fish oil (providing 2.7 g/d EPA and DHA) and antioxidants (vitamins A, C and E, and Se) (n 31) or placebo (n 30) for 24 weeks. Bone turnover was assessed by measuring the concentrations of urinary deoxypyridinoline (bone resorption) and serum osteocalcin (bone formation). Fish oil plus antioxidants were associated with increases in EPA, DHA Se in plasma (all P < 0.01), and with a reduction in interferon-gamma production by mitogen-stimulated PBMC, which demonstrated a negative correlation with deoxypyridinoline/creatinine:osteocalcin ratio (r - 0.33, P = 0.009). There were no differences between the groups at 24 weeks in the response of deoxypyridinoline or osteocalcin or their ratio, or in nutritional status. Dietary supplementation in Crohn's disease with high intakes of EPA and DHA, as fish oil, plus antioxidants was associated with a modulated production of interferon-gamma by PBMC but not altered indices of bone turnover.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1079/BJN20051466
ISSNs: 0007-1145 (print)
Keywords: bone, fish oil, crohn's disease
ePrint ID: 62170
Date :
Date Event
August 2005Published
Date Deposited: 29 Oct 2008
Last Modified: 16 Apr 2017 17:30
Further Information:Google Scholar
URI: http://eprints.soton.ac.uk/id/eprint/62170

Actions (login required)

View Item View Item